These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34778222)

  • 1. Effect of Novel Polymer-Free Nitrogen-Doped Titanium Dioxide Film-Coated Coronary Stent Loaded With Mycophenolic Acid.
    Shim JW; Kim SS; Kim HK; Bae IH; Park DS; Park JK; Kim JU; Kim HB; Lee MY; Kim JS; Kim JH; Koo BS; Jeong KJ; Kim SU; Kim MC; Sim DS; Hong YJ; Ahn Y; Lim KS; Jeong MH
    Front Bioeng Biotechnol; 2021; 9():650408. PubMed ID: 34778222
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of polymer-free TiO2 stent coated with abciximab or alpha lipoic acid in porcine coronary restenosis model.
    Lim KS; Jeong MH; Bae IH; Park JK; Park DS; Kim JM; Kim JH; Kim HS; Kim YS; Jeong HY; Song SJ; Yang EJ; Cho DL; Sim DS; Park KH; Hong YJ; Ahn Y
    J Cardiol; 2014 Nov; 64(5):409-18. PubMed ID: 24852847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel polymer-free drug-eluting stent coated with everolimus using nitrogen-doped titanium dioxide film deposition in a porcine coronary restenosis model.
    Sim DS; Jeong MH; Park DS; Kim JH; Lim KS; Bae IH; Zhehao P; Yang HY; Lee JH; Hyun DY; Hong YJ; Kim JH; Ahn Y; Kang JC
    Int J Cardiol; 2016 Nov; 222():436-440. PubMed ID: 27505330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of a novel polymer-free everolimus-eluting stent by nitrogen-doped titanium dioxide film deposition.
    Park DS; Bae IH; Jeong MH; Lim KS; Sim DS; Hong YJ; Lee SY; Jang EJ; Shim JW; Park JK; Lim HC; Kim HB
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():615-623. PubMed ID: 30033294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel polymer-free everolimus-eluting stent with a nitrogen-doped titanium dioxide film inhibits restenosis and thrombosis in a swine coronary model.
    Hyun DY; Han X; Park DS; Kim M; Park JK; Cho KH; Sim DS; Hong YJ; Ahn Y; Jeong MH
    Cardiol J; 2023 Feb; 30(6):881-91. PubMed ID: 36790043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological Comparison among Biolimus, Zotarolimus and Everolimus-Eluting Stents in Porcine Coronary Restenosis Model.
    Lim KS; Jeong MH; Bae IH; Park DS; Kim JM; Kim JH; Cho DL; Sim DS; Park KH; Hong YJ; Ahn Y
    Korean Circ J; 2013 Nov; 43(11):744-51. PubMed ID: 24363750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
    Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
    Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery.
    Ijichi T; Nakazawa G; Torii S; Nagamatsu H; Yoshikawa A; Souba J; Isobe A; Hagiwara H; Ikari Y
    PLoS One; 2019; 14(1):e0209841. PubMed ID: 30629613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
    Sperling C; Waliszewski MW; Kherad B; Krackhardt F
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable polymer-coated thin strut sirolimus- -eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population.
    Gasior P; Gierlotka M; Szczurek-Katanski K; Osuch M; Roleder M; Hawranek M; Wojakowski W; Polonski L
    Cardiol J; 2021; 28(2):235-243. PubMed ID: 31909473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of stents coated with a combination of sirolimus and alpha-lipoic acid in a porcine coronary restenosis model.
    Lim KS; Park JK; Jeong MH; Bae IH; Nah JW; Park DS; Kim JM; Kim JH; Lee SY; Jang EJ; Jang S; Kim HK; Sim DS; Park KH; Hong YJ; Ahn Y; Kang JC
    J Mater Sci Mater Med; 2016 Apr; 27(4):66. PubMed ID: 26886814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
    Buszman PP; Milewski K; Pająk J; Jelonek M; Orlik B; Krauze A; Gwiazdowska-Nowotka B; Wojakowski W; Tellez A; Granada JF; Buszman PE
    EuroIntervention; 2014 Oct; 10(6):724-31. PubMed ID: 24469344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.
    Sheehy A; Hsu S; Bouchard A; Lema P; Savard C; Guy LG; Tai J; Polyakov I
    Cardiovasc Diabetol; 2012 Jun; 11():75. PubMed ID: 22716997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ramiprilat-coated stents on neointimal hyperplasia, inflammation, and arterial healing in a porcine coronary restenosis model.
    Hong YJ; Jeong MH; Song SJ; Sim DS; Kim JH; Lim KS; Hachinohe D; Ahmed K; Hwang SH; Lee MG; Ko JS; Park KH; Yoon HJ; Yoon NS; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Cho DL; Park JC; Kang JC
    Korean Circ J; 2011 Sep; 41(9):535-41. PubMed ID: 22022329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic response after hydrophilic polyethylene glycol-coating stent and hydrophobic octadecylthiol-coating stent implantations in porcine coronary restenosis model.
    Choe JC; Park JH; Lee HC; Park TS; Ahn J; Park JS; Lee HW; Oh JH; Choi JH; Cha KS; Yim C; Jeon S
    J Mater Sci Mater Med; 2020 Nov; 31(12):122. PubMed ID: 33247775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial.
    Tonino PAL; Pijls NHJ; Collet C; Nammas W; Van der Heyden J; Romppanen H; Kervinen K; Airaksinen JKE; Sia J; Lalmand J; Frambach P; Penaranda AS; De Bruyne B; Karjalainen PP;
    JACC Cardiovasc Interv; 2020 Jul; 13(14):1697-1705. PubMed ID: 32703593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial.
    Teeuwen K; van der Schaaf RJ; Adriaenssens T; Koolen JJ; Smits PC; Henriques JP; Vermeersch PH; Tjon Joe Gin RM; Schölzel BE; Kelder JC; Tijssen JG; Agostoni P; Suttorp MJ
    JACC Cardiovasc Interv; 2017 Jan; 10(2):133-143. PubMed ID: 28104206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).
    Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; den Heijer P; van der Ent M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1215-1221. PubMed ID: 28579236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Stents Coated with Artemisinin or Dihydroartemisinin in a Porcine Coronary Restenosis Model.
    Jang S; Jeong MH; Lim KS; Bae IH; Park JK; Park DS; Shim JW; Kim JH; Kim HK; Sim DS; Hong YJ; Ahn Y; Kang JC
    Korean Circ J; 2017 Jan; 47(1):115-122. PubMed ID: 28154599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus-Eluting Biodegradable Polymer Versus Everolimus-Eluting Durable Polymer Stent for Coronary Revascularization in Routine Clinical Practice.
    Zanchin C; Ueki Y; Zanchin T; Häner J; Otsuka T; Stortecky S; Koskinas KC; Siontis GCM; Praz F; Moschovitis A; Hunziker L; Valgimigli M; Pilgrim T; Heg D; Windecker S; Räber L
    JACC Cardiovasc Interv; 2019 Sep; 12(17):1665-1675. PubMed ID: 31422088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.